luminex microspheres (DiaSorin Biotechnology)
DiaSorin Biotechnology is a verified supplier 
DiaSorin Biotechnology manufactures this product 
97
Structured Review
DiaSorin Biotechnology
luminex microspheres
Luminex Microspheres, supplied by DiaSorin Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1448 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/flexmap+3d+array+reader/MagPlex+microspheres/us12383526-85-24-24
Average 97 stars, based on 1448 article reviews
Luminex Microspheres, supplied by DiaSorin Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1448 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/flexmap+3d+array+reader/MagPlex+microspheres/us12383526-85-24-24
Average 97 stars, based on 1448 article reviews
luminex microspheres - by Bioz Stars,
2026-10
97/100 stars
Images
Related Articles
Sequencing:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Luminex:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Suspension:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Polymerase Chain Reaction:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Fluorescence:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Amplification:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Ligation:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Incubation:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Concentration Assay:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Multiplex Assay:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Serologic Assay:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Labeling:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Conjugation Assay:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Expressing:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Expression Vector:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Transfection:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Control:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Purification:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Plasmid Preparation:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Recombinant:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Western Blot:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Microarray:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Diagnostic Assay:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Virus:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. Aqueous Normal-phase Chromatography:Article Title: Avidity as a marker of protection against hepatitis E during a genotype 1 outbreak in South Sudan Article Snippet: PrePrint: ting no effect of urea treatment on antigen integrity (Supplementary Figure S2). We also assessed the presence of IgG antibodies against the ORF2 Wantai antigen using a bead-based Luminex immunoassay. |